Cambridge Healthtech Institute’s 11th Annual
Antibodies for Cancer Therapy
Driving Breakthrough Therapies
May 11-12, 2021
The 11th Annual Antibodies for Cancer Therapy conference at PEGS will bring together an all-star faculty to explore current approaches, latest results and best practices for moving antibodies into the clinic. This year’s program will feature combining
radiotherapy and immunotherapy; bioinformatic approaches for target discovery and validation; glypicans as an emerging class of targets; and bioengineered antibodies for recycled targets using innovative strategies. Gain insight by joining this esteemed
roster of experts and learn from both the presentations as well as the in-depth panel discussions. This year’s platform will expand the interactive features to facilitate the exchange of ideas.
Coverage will include, but is not limited to:
- Moving antibodies to the clinic
- Evaluating emerging targets
- Engaging specific immune cell populations
- Debating options for modulating delivery routes, minimizing adverse reactions and extending half-life
- Using bioinformatics and computational modeling to build a better antibody
If you would like to submit a proposal to give a presentation at this meeting, please click here.
The deadline for priority consideration is November 6, 2020.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
For more details on the conference, please contact:
Executive Director, Conferences and Fellow
For partnering and sponsorship information, please contact:
Senior Manager, Business Development
Phone: 781-972-5452 Email: email@example.com
Manager, Business Development
Phone: 781-972-1340 Email: firstname.lastname@example.org